J·E·拉马

TL;DR: In this article, the authors present peptidomimetic compounds useful as protease inhibitors, particularly as serine proteases inhibitors and more particularly as hepatitis C NS3 protease inhibitor; intermediates thereto; their preparation including novel steroselective processes to intermediates; their methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an infection or physiological condition related to the infection.